Zum Hauptinhalt springen
xMedica

Suchen

170 Studien passen zu diesen Filtern. 1–25 von 170 Studien werden angezeigt

Suchergebnisse
RegistrierungsnummerStudieStatusPhaseTeilnahmeStudienzentren / LänderStartjahrZuletzt aktualisiertAktionen
NCT07213778REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants

This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called Acetylsalicylic Acid (ASA). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to…

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Wichita, Kansas, United States — 43 km entfernt · 57 Zentren insgesamt

RekrutiertPhase 32.000Zielwert57 / 5202519. Nov. 2026
NCT04613596Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

The Phase 2 portion of this study evaluates the efficacy and safety of MRTX849 monotherapy and in combination with pembrolizumab in cohorts of patients with advanced NSCLC with KRAS G12C mutation and any PD-L1 TPS and who are candidates for first-line treatment. The Phase 3 portion of the study com…

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Kingman, Kansas, United States — 28 km entfernt · 776 Zentren insgesamt · Kontakt angegeben

RekrutiertPhase 2 / Phase 3626Zielwert776 / 47202019. Nov. 2026
NCT06956014Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy

The aim of the trial is to prove the efficacy and safety of VER-01 compared to placebo in patients with chronic painful lumbosacral radiculopathy (PLSR) for whom drug treatment is indicated and previous optimized treatments with non-opioid analgesics have not led to sufficient pain relief or were un…

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Wichita, Kansas, United States — 43 km entfernt · 43 Zentren insgesamt · Kontakt angegeben

RekrutiertPhase 3810Zielwert43 / 1202619. Nov. 2026
NCT07466316A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

This phase III trial compares higher dose chemotherapy, with vincristine, dactinomycin and cyclophosphamide, over a shorter amount of time to lower dose chemotherapy plus maintenance, with vincristine, dactinomycin, cyclophosphamide, irinotecan and vinorelbine, over a longer amount of time, along wi…

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Wichita, Kansas, United States — 43 km entfernt · 138 Zentren insgesamt · Kontakt angegeben

RekrutiertPhase 3342Zielwert138 / 2202619. Nov. 2026
NCT02402244Project: Every Child for Younger Patients With Cancer

This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Wichita, Kansas, United States — 43 km entfernt · 279 Zentren insgesamt · Kontakt angegeben

Rekrutiert75.000Zielwert279 / 6201519. Nov. 2026
NCT06581328A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this study is to check for how many participants with UC and CD signs and symptoms disappear after 3.5 months…

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Hutchinson, Kansas, United States — 36 km entfernt · 101 Zentren insgesamt · Kontakt angegeben

RekrutiertPhase 4200Zielwert101 / 1202518. Nov. 2026
NCT07685808Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

This study will test an experimental drug called olatorepatide ("study drug") to determine how safe and effective this drug is compared to placebo and how easily the body can accept this drug at different doses and dosing schedules without causing side effects, as well as how the drug is processed i…

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Wichita, Kansas, United States — 43 km entfernt · 22 Zentren insgesamt

RekrutiertPhase 2360Zielwert22 / 1202618. Nov. 2026
NCT06393374Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compared to treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received neoadjuvant therapy and di…

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Wichita, Kansas, United States — 43 km entfernt · 317 Zentren insgesamt

RekrutiertPhase 31.530Zielwert317 / 31202418. Nov. 2026
NCT07629440A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.

The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germs that can cause pneumonia (lung infections), meningitis (brain infections), and otitis media (ear infections) in infants when compared to the pneumoco…

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Derby, Kansas, United States — 54 km entfernt · 134 Zentren insgesamt

RekrutiertPhase 33.230Zielwert134 / 3202618. Nov. 2026
NCT07636590Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency

The goal of this non-interventional, observational study is to describe the natural history, clinical course, and management patterns of subjects with limbal stem cell deficiency (LSCD).

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Wichita, Kansas, United States — 43 km entfernt · 21 Zentren insgesamt · Kontakt angegeben

Rekrutiert500Zielwert21 / 1202618. Nov. 2026
NCT07780669A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

The study primarily aims to demonstrate the superiority of GSK5784283 as an add-on therapy compared to placebo in reducing the annualized rate of moderate and severe chronic obstructive pulmonary disease (COPD) exacerbations.

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Derby, Kansas, United States — 54 km entfernt · 11 Zentren insgesamt · Kontakt angegeben

RekrutiertPhase 3624Zielwert11 / 2202617. Nov. 2026
NCT07159763A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)

Approximately one billion cases of seasonal influenza occur annually. Of these, 3 to 5 million illnesses are severe and responsible for up to 650,000 deaths per year (WHO 2025). Yearly administration of an influenza vaccine for the prevention of influenza is currently recommended. However, the real-…

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Hutchinson, Kansas, United States — 36 km entfernt · 211 Zentren insgesamt · Kontakt angegeben

RekrutiertPhase 310.000Zielwert211 / 6202517. Nov. 2026
NCT07915791A Study to Assess the Efficacy and Safety of Co-administration of GSK3862995B With GSK5784283 in Adult Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

This study is for adult participants with moderate to severe Chronic Obstructive Pulmonary Disease (COPD) who continue to experience exacerbations despite standard of care triple therapy treatment. It will assess the effectiveness and safety of two investigational drugs, GSK3862995B and GSK5784283,…

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Derby, Kansas, United States — 54 km entfernt · 10 Zentren insgesamt · Kontakt angegeben

RekrutiertPhase 2279Zielwert10 / 2202617. Nov. 2026
NCT07746531Robotic Minimally Invasive Benign Hysterectomy Post-Market Clinical Study With the DEXTER Robotic System

The purpose of this post-market, observational study is to collect real-world data under anticipated conditions of use that demonstrates that the device performs as intended (accurate, precise control of surgical instruments) in patients undergoing robotic-assisted and laparoscopic hysterectomy for benign disease.

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Wichita, Kansas, United States — 43 km entfernt · 2 Zentren insgesamt · Kontakt angegeben

Rekrutiert112Zielwert2 / 1202617. Nov. 2026
NCT04566328Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethasone). Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell g…

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Kingman, Kansas, United States — 28 km entfernt · 647 Zentren insgesamt

RekrutiertPhase 31.450Zielwert647 / 2202116. Nov. 2026
NCT07136012OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And Lipoprotein(a) Reduction to Prevent First Major Cardiovascular Events

The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardial infarction, or urgent coronary revascularization in participants at risk for a first major cardiovascular event with elevated lipoprotein(a) (Lp\[a\]).

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Hutchinson, Kansas, United States — 36 km entfernt · 261 Zentren insgesamt

RekrutiertPhase 311.000Zielwert261 / 4202516. Nov. 2026
NCT07543120An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.

The purpose of this extension study is to collect additional safety and efficacy on QCZ484 for hypertensive patients who successfully completed the parent study, CQCZ484A12201 or additional QCZ484 studies as specified in the respective parent study protocols.

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Wichita, Kansas, United States — 43 km entfernt · 46 Zentren insgesamt · Kontakt angegeben

RekrutiertPhase 2323Zielwert46 / 3202616. Nov. 2026
NCT07220083A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

PODOMOUNT-pFSGS This study is open to adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS). The purpose of this study is to find out whether a medicine called BI 764198 helps people with FSGS. Participants are put into 2 groups randomly, which means by ch…

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Wichita, Kansas, United States — 43 km entfernt · 309 Zentren insgesamt · Kontakt angegeben

RekrutiertPhase 3286Zielwert309 / 37202613. Nov. 2026
NCT07190300TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

The purpose of this study is to evaluate the safety, tolerability, and efficacy of two different treatment combinations of tulmimetostat in participants with de novo or recurrent metastatic hormone-sensitive prostate cancer (mHSPC). Phase I aims to determine the recommended dose(s) for expansion (RD…

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Wichita, Kansas, United States — 43 km entfernt · 31 Zentren insgesamt · Kontakt angegeben

RekrutiertPhase 1 / Phase 2181Zielwert31 / 14202613. Nov. 2026
NCT07798726TransCatheter Replacement Of the Mitral Valve With the Novel Cephea Mitral Valve System

The objective of this clinical trial is to evaluate the safety and effectiveness of the Cephea Mitral Valve System in subjects with symptomatic mitral valve disease (MVD) or are deemed unsuitable for surgery and transcatheter repair.

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Wichita, Kansas, United States — 43 km entfernt · Kontakt angegeben

RekrutiertNicht zutreffend565Zielwert1 / 1202613. Nov. 2026
NCT06819878A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

This Phase III, multicenter, double-blind, placebo-controlled treat-through study will evaluate the efficacy and safety of induction and maintenance therapy with Afimkibart (also known as RO7790121) in participants with moderately to severely active Crohn's disease (CD).

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Wichita, Kansas, United States — 43 km entfernt · 375 Zentren insgesamt

RekrutiertPhase 3600Zielwert375 / 38202513. Nov. 2026
NCT06935370A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

This study is open to adults with chronic heart failure (HF) who have a reduced left ventricular ejection fraction (LVEF) of less than 40%. People can join the study if they have been diagnosed with chronic HF at least 3 months before they start on the study. The purpose of this study is to find out…

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Wichita, Kansas, United States — 43 km entfernt · 596 Zentren insgesamt · Kontakt angegeben

RekrutiertPhase 34.200Zielwert596 / 29202512. Nov. 2026
NCT07064473EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empaglifl…

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Wichita, Kansas, United States — 43 km entfernt · 1.142 Zentren insgesamt · Kontakt angegeben

RekrutiertPhase 311.800Zielwert1.142 / 51202512. Nov. 2026
NCT06424288A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular ejection fraction (LVEF) of 40% or more. The purpose of this study is to find out whether vicadrostat (BI 690517) in combination with empag…

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Wichita, Kansas, United States — 43 km entfernt · 672 Zentren insgesamt · Kontakt angegeben

RekrutiertPhase 36.712Zielwert672 / 30202412. Nov. 2026
NCT07321899Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation

This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.

✓ Kontakt✗ Beansprucht

Nächstes Studienzentrum: Wichita, Kansas, United States — 43 km entfernt · 20 Zentren insgesamt · Kontakt angegeben

RekrutiertNicht zutreffend1.186Zielwert20 / 1202612. Nov. 2026

Filter